XKRX:389470 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
9810.00
(-0.1%)
May 27
Current and historical daily PE Ratio for Inventage Lab Inc (
XKRX:389470
) from 2022 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Inventage Lab stock (XKRX:389470) PE ratio as of May 27 2024 is 0.
More Details
Inventage Lab Inc (XKRX:389470) PE Ratio (TTM) Chart
Inventage Lab Inc (XKRX:389470) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 384
- 1
- 2
- 3
- 4
- 5
| Inventage Lab PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-27 | At Loss | 2024-03-20 | At Loss |
| 2024-05-27 | At Loss | 2024-03-19 | At Loss |
| 2024-05-24 | At Loss | 2024-03-18 | At Loss |
| 2024-05-23 | At Loss | 2024-03-15 | At Loss |
| 2024-05-22 | At Loss | 2024-03-14 | At Loss |
| 2024-05-21 | At Loss | 2024-03-13 | At Loss |
| 2024-05-20 | At Loss | 2024-03-12 | At Loss |
| 2024-05-17 | At Loss | 2024-03-11 | At Loss |
| 2024-05-16 | At Loss | 2024-03-08 | At Loss |
| 2024-05-14 | At Loss | 2024-03-07 | At Loss |
| 2024-05-13 | At Loss | 2024-03-06 | At Loss |
| 2024-05-10 | At Loss | 2024-03-05 | At Loss |
| 2024-05-09 | At Loss | 2024-03-04 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-03 | At Loss | 2024-02-27 | At Loss |
| 2024-05-02 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-23 | At Loss |
| 2024-04-29 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-08 | At Loss |
| 2024-04-16 | At Loss | 2024-02-07 | At Loss |
| 2024-04-15 | At Loss | 2024-02-06 | At Loss |
| 2024-04-12 | At Loss | 2024-02-05 | At Loss |
| 2024-04-11 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-05 | At Loss | 2024-01-30 | At Loss |
| 2024-04-04 | At Loss | 2024-01-29 | At Loss |
| 2024-04-03 | At Loss | 2024-01-26 | At Loss |
| 2024-04-02 | At Loss | 2024-01-25 | At Loss |
| 2024-04-01 | At Loss | 2024-01-24 | At Loss |
| 2024-03-29 | At Loss | 2024-01-23 | At Loss |
| 2024-03-28 | At Loss | 2024-01-22 | At Loss |
| 2024-03-27 | At Loss | 2024-01-19 | At Loss |
| 2024-03-26 | At Loss | 2024-01-18 | At Loss |
| 2024-03-25 | At Loss | 2024-01-17 | At Loss |
| 2024-03-22 | At Loss | 2024-01-16 | At Loss |
| 2024-03-21 | At Loss | 2024-01-15 | At Loss |
Inventage Lab Inc (XKRX:389470) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Inventage Lab Inc
ISIN : KR7389470006
Share Class Description:
XKRX:389470: Ordinary SharesCompare
Compare
Traded in other countries / regions
389470.Korea IPO Date
2022-11-23Description
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers